Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment
Zhenghao Chen, Helga Simon‐Molas, Gaspard Cretenet, et al.
Blood (2022) Vol. 140, Iss. 6, pp. 630-643
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Tengyue Hu, Changhai Liu, Min Lei, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as therapeutic strategy in CLL
Anne Largeot, Vanessa Klapp, Elodie Viry, et al.
Blood (2023)
Open Access | Times Cited: 19
Emerging Therapies in CLL in the Era of Precision Medicine
Prajish Iyer, Lili Wang
Cancers (2023) Vol. 15, Iss. 5, pp. 1583-1583
Open Access | Times Cited: 16
Improved Photodynamic Therapy Based on Glutaminase Blockage via Tumor Membrane Coated CB‐839/IR‐780 Nanoparticles
Zhiyan Li, Xianghui Li, Yanjun Lu, et al.
Small (2023) Vol. 20, Iss. 10
Closed Access | Times Cited: 13
Metabolic reprogramming in the CLL TME; potential for new therapeutic targets
Helga Simon‐Molas, Chiara Montironi, Anna Kabanova, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 3, pp. 155-162
Open Access | Times Cited: 4
The multi-faceted roles of MYC in the prognosis of chronic lymphocytic leukemia
Loïc Ysebaert, Pierre‐Luc Mouchel, Camille Laurent, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-13
Closed Access
Metabolic reprogramming, malignant transformation and metastasis: lessons from chronic lymphocytic leukaemia and prostate cancer.
Madison T. Hindes, Anthony M. McElligott, Giles Best, et al.
Cancer Letters (2025), pp. 217441-217441
Closed Access
BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia
Annalisa Chiarenza, Gaia Vertillo Aluisio, Nunziatina Laura Parrinello, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Lessons learned from the Eµ-TCL1 mouse model of CLL
Alessia Floerchinger, Martina Seiffert
Seminars in Hematology (2024) Vol. 61, Iss. 3, pp. 194-200
Open Access | Times Cited: 3
Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma
Aliza Mushtaq, Ismaheel O. Lawal, Saima Muzahir, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 13, pp. 4073-4082
Closed Access | Times Cited: 3
Complementary approaches define the metabolic features that accompany Richter syndrome transformation
Giulia Omezzolli, Andrea Iannello, Francesco Edoardo Vallone, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma
Yvonne J. Thus, Eric Eldering, Arnon P. Kater, et al.
Leukemia (2022) Vol. 36, Iss. 9, pp. 2165-2176
Open Access | Times Cited: 16
Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation
Karoline Kielbassa, Marco V. Haselager, Danique Bax, et al.
Leukemia (2023) Vol. 37, Iss. 6, pp. 1268-1276
Open Access | Times Cited: 9
Role of the tumor microenvironment in CLL pathogenesis
Alexander F. vom Stein, Michael Hallek, Phuong‐Hien Nguyen
Seminars in Hematology (2023) Vol. 61, Iss. 3, pp. 142-154
Open Access | Times Cited: 9
Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival
Flora Nguyen Van Long, Délya Valcourt‐Gendron, Patrick Caron, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 12
Open Access | Times Cited: 7
The complexities of T-cell dysfunction in chronic lymphocytic leukemia
Elena Camerini, Derk Amsen, Arnon P. Kater, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 3, pp. 163-171
Open Access | Times Cited: 2
Extracellular Vesicles in Chronic Lymphocytic Leukemia: Tumor Microenvironment Messengers as a Basis for New Targeted Therapies?
Kenza Dubois, Mariana Tannoury, Brigitte Bauvois, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2307-2307
Open Access | Times Cited: 6
ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia
Mariana Tannoury, Marianne Ayoub, Léa Dehgane, et al.
Leukemia (2023) Vol. 38, Iss. 2, pp. 302-317
Open Access | Times Cited: 6
Advances in Understanding of Metabolism of B-Cell Lymphoma: Implications for Therapy
Katarína Kľučková, Annalisa D’Avola, John C. Riches
Cancers (2022) Vol. 14, Iss. 22, pp. 5552-5552
Open Access | Times Cited: 9
Electron transport chain and mTOR inhibition synergistically decrease CD40 signaling and counteract venetoclax resistance in chronic lymphocytic leukemia
Zhenghao Chen, Gaspard Cretenet, Valeria Carnazzo, et al.
Haematologica (2023)
Open Access | Times Cited: 5
Current Status of Novel Agents for the Treatment of B Cell Malignancies: What’s Coming Next?
Mariana Tannoury, Delphine Garnier, Santos A. Susín, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6026-6026
Open Access | Times Cited: 8
Glucose metabolism in B cell malignancies: a focus on glycolysis branching pathways
Helga Simon‐Molas, Rosita Del Prete, Anna Kabanova
Molecular Oncology (2023) Vol. 18, Iss. 7, pp. 1777-1794
Open Access | Times Cited: 3
Discovery of orally active 1,4,5,6,8-pentaazaacenaphthylens as novel, selective, and potent covalent BTK inhibitors for the treatment of rheumatoid arthritis
Xiaobao Fang, Chunxiao Liu, Kun Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114940-114940
Closed Access | Times Cited: 3
Metabolic signature and response to glutamine deprivation are independent of p53 status in B cell malignancies
Chiara Montironi, Zhenghao Chen, Ingrid A. M. Derks, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109640-109640
Open Access
Revealing putative causal genes by establishing the causality between different lymphomas and immune cells
Jingxuan Lian, Xinghong Zhang, Wenjie Chen, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top